The type III TGF-β receptor suppresses breast cancer progression through GIPC-mediated inhibition of TGF-β signaling

Jason D. Lee(Duke University Hospital), Gerard C. Blobe(Duke University Hospital)
Carcinogenesis
December 2, 2009
Cited by 60


Related Papers